In the current work, Lira has activated p-PI3K and p-Akt to concur with the findings of Yang et al. (2018) in a model of type 2 diabetes, where Lira mediated its neuroprotective effect and improved cognitive function through triggering the PI3K/Akt hub. This evidence concerns the gene AKT1 and type 2 diabetes mellitus.